Synta Pharmaceuticals is an innovative, agile biopharmaceutical company focused on research, development and commercialization of novel oncology medicines that have the potential to change the lives of cancer patients.


Patents show all


Clinical Trials show all

17Phase 114Phase 25Phase 1/Phase 22Phase 31Other

SEC Filings show all


Contact Information

45 Hartwell Avenue
Lexington, MA 02421
United States

(781) 274-8200


    Total FundingEmployeesLast Funding DateStatus

    Crunchbase Investment Rounds

    DateAmountRoundValuationLead InvestorOther Investors
    2015-04-01$38,500,000Post Ipo Equity
    2010-01-08$23,100,000Post Ipo Equity
    2006-10-22$40,000,000Series Unknown
    2004-01-14$50,000,000Series CDuquesne Capital Management, SunAmerica, Caxton Associates, Galleon Group, Gollust Management, Mountain Trail Investments
    2002-05-31$12,000,000Series Unknown
    2004-12-07Series D
    2010-01-19$3,750,000Series Unknown
    2003-04-21$50,000,000Series B

    SEC Form D Funding Events

    2004-12-07UnknownUnknownOther (Paper Filing)